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Graft rejection does not occur in vivo in the absence ofT cells (1-4). It is not known 
however whether  T  cells  alone  can  mediate  graft  rejection.  Indeed  the  invariable 
association of B-cell responses,  including alloantibody synthesis, with graft rejection 
in normal animals suggests that  the requirements  for rejection may be complex and 
at  least  partly  B-cell  dependent  (4-6).  However,  the  association  of a  particular 
immune response with graft rejection does not necessarily imply that it is a  require- 
ment  for rejection  (5).  The cellular  requirements  for graft  rejection  in  vivo can  be 
directly established by adapting the adoptive transfer technique (7) and testing known 
cell  populations  singly  or  in  combination  for  their  ability  to  cause  rejection  in 
irradiated  animals bearing allografts (8-10). 
Large  doses  of irradiation  are  required  to  ensure  consistent  ablation  of first-set 
allograft responses (8). As the rat is very sensitive to the rapidly-fatal gastrointestinal 
syndrome after conventional irradiation  techniques  (11)  successful adaptation of the 
adoptive transfer system to study of the response to antigens of the major histocom- 
patibility complex (MHC)1 depends on careful attention to the parameters of irradia- 
tion  to ensure  a  uniform  whole-body dose close to the  LD10/30  days.  Under  such 
optimal  conditions  the  irradiated  rats  provide  an  immunologically-inert  milieu  in 
which the host cells make no detectable contribution to the specificity of the immune 
response and the immune potential  of adoptively transferred  cells can be accurately 
determined  (7,  8).  Using  microsurgical  anastomosis  of adult  heart  grafts  in  such 
animals we have previously shown that the potency of adoptively transferred inocula 
of lymphocytes can be measured  with  precision  (10).  The cellular  requirements  for 
first-set graft rejection in the rat have now been studied with the same assay system. 
Materials  and Methods 
Animals.  Inbred rats of the strains PVG-H-1  c (Ag-B5), LEW H-1 e (Ag-B1), DA H-1 a (Ag- 
B4), BN H-1 n (Ag-B3), and AUG H-1 c were bred in our own animal house. Nomenclature of 
rat strains is from Rat Newsletter, no. 3, 1978; Medical Research Council Laboratory Animals 
Center. 
Irradiation.  Animals lying horizontally in a Perspex box were rotated at  16 rpm around the 
vertical axis in a horizontal beam from a S°Co source at a distance of 25 cm. The beam was 
filtered with shaped lead discs to an isodose uniformity of>96% and was directed into a lead 
cave where irradiation occurred under conditions of maximum backscatter, at a dose rate of 50 
* Supported by grants from the National Health Medical Research Council, the N. S. W. State Cancer 
Council, and the University of Sydney Cancer Research Fund. 
1 Abbreviations  used in this paper: DAB/BSA, Dulbecco's phosphate-buffered saline containing 0.3% wt/vol 
bovine serum albumin; HU, hydroxyurea; Ig+, lymphocytes bearing surface immunoglobulin detectable 
with fluoresceinated rabbit  antibodies to rat  immunoglobulins; LNC, lymph node cells; MHC,  major 
histocompatibility complex; TDL, thoracic duct lymphocytes; VBL, vinblastine sulphate. 
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rads/min. The irradiation time was calculated by a program which corrected for isotope decay 
and was timed electronically to a reproducibility of >99.9%. 
Heart Grafting.  Hearts were removed from adult donors immediately after an intravenous 
injection of 50 U of preservative-free heparin. Donors had been irradiated with 750 rads within 
the previous 6 h. Hearts were anastomosed to the abdominal great vessels by a modification of 
the technique of Ono and Lindsey (12). Irradiated recipients of heart grafts were given 750 
rads, the optimal dose for ablation of the allograft response (8), within 6 h before surgery. The 
end point of graft rejection was loss of palpable heart beat confirmed by loss of electrocardiogram 
activity. 
Statistics.  Because the rejection times of grafts in experimental groups of animals fall within 
a  narrow range of values it is appropriate to express  results in terms of mean survival values 
:t=  a  standard  error  and  to  estimate  the  significant differences  between  groups  using the 
Student's t test. 
Cell  Preparations.  Thoracic  duct  lymphocytes (TDL)  were  obtained from  an  indwelling 
cannula by the method of Gowans and Knight (13). Lymph was collected at 4°C. Cells were 
washed  twice by centrifugation in Dulbecco's phosphate-buffered saline with calcium and 
magnesium (DAB,  Oxoid) containing 0.3% bovine serum albumin (Armour Pharmaceutical 
Co. Ltd., Hampden Park, East Bourne Sussex, U.K.) (DAB/BSA). Single cell suspensions were 
prepared from pooled cervical and mesenteric lymph nodes or spleen by crushing between 
the flatground bottom of a 50-ml beaker and the floor of a Petri dish containing DAB/BSA. 
Thymocytes were obtained by the same method. Thymus donors were injected intraperitoneally 
with 1 ml of a 1:100 dilution of colloidal carbon (Pelikan 518 Gunther Wagner) 24 h previously 
to stain the parathymic lymph nodes which were carefully removed before crushing. Bone 
marrow cells were flushed from the tibiae and femora using DAB/BSA and clumps broken up 
by repeated pipetting. All cell suspensions were filtered through four layers of sterile surgical 
gauze before washing twice in DAB/BSA. Dead cells were removed where necessary by flotation 
on isotonic 35% BSA solution pH 7.4 (14). 
In  Vitro Cell Separation.  Lymphocytes negative for membrane-bound immunoglobulin  (Ig-) 
were obtained from cell preparations by selective adherence of immunoglobulin-bearing  (Ig +) 
B cells to affinity-purified, sheep anti-rat IgG, immobilized on solid supports. Supports were 
either columns of coarse  G50-Sephadex activated with  periodate by a  modification of the 
method of Wilson and Nakane (15) or tissue culture grade Petri dishes  (BioQuest, BBL & 
Falcon Products, Becton, Dickinson & Co., Cockeysville,  Md.) coated by the method of Mage 
et al.  (16). In both techniques the yield of T  cells was 69-90% and contamination with Ig+ 
cells was less than 5%. 
Immunofluorescence.  Cell-membrane immunofluorescent stains were done at 22°C in DAB/ 
BSA containing 0.02 M sodium azide, on cell suspensions at  10a/ml which were >90% viable 
by nigrosine exclusion. Preparations were stained for Ig+ cells with fluorescent rabbit anti-rat 
immunoglobulin  (Burroughs Wellcome). Cells were stained for 30 min, washed once in DAB/ 
BSA, then resuspended in 3 ml DAB/BSA - azide and layered on 4 ml 6% BSA in DAB also 
containing  0.02 M azide and pelleted by centrifugation at 350 g for 10 min. Careful aspiration 
of the supernate removed all non cell-bound reagent. The pellet was resuspended in one to two 
drops of 6% BSA-azide, smeared, dried, and fixed for 10 min in absolute reagent-grade ethanol 
before drying and mounting in glycerol buffered to pH 9.8. Slides were examined with a Leitz 
microscope with Ploempak incident-light fluorescence and combined transmitted-light phase 
contrast  optics.  Where  cell  preparations  contained erythrocytes  these  were  removed  after 
fixation by immersing the slides for  1-2 min in distilled water containing 13 g/liter cetrimide 
and washing thoroughly in distilled water. This treatment completely lysed erythrocytes and 
did not remove either fluorescent stain or nucleated cells. T-cell markers were demonstrated by 
two stage techniques using fluorescent anti-Ig reagents at the second-stage. After first  stage 
staining the cells were washed once in DAB/BSA before layering on 6% BSA and centrifuging 
to ensure complete removal of non cell-bound antibody before second-stage staining with anti- 
immunoglobulin. First stage reagents were  (a)  AUG anti-PVG alloantisera prepared by the 
method of Howard and Scott  (17) to detect the Pta antigens, A2 and B (not  1), which are 
present only on peripheral T cells in the PVG rat  2 and W3/13 antibody recently described by 
2 G. W. Butcher and J. C. Howard. Rat Newsletter, no. 1. M. Festing, editor. MRC Laboratory Animal 
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Williams et al.  (18) produced by mouse-mouse hybrid plasma cell clones in vitro. W3/13 binds 
to both thymocytes and peripheral T cells in the rat, (b) a rabbit anti-Thy-1.1 antiserum, which 
had been extensively absorbed to render it specific  for Thy-l.1. This reagent binds strongly to 
rat  thymocytes (19) and  binding to TDL can be detected using a  polyvalent anti-Ig second 
stage reagent  (20). The second stage reagent for anti-Pta antibody and specificity W3/13 was 
fluorescent rabbit anti-rat Ig and for Thy-1.1 antibody was sheep-anti-rabbit Ig. 
Plasma cells in histological sections were stained directly with the fluorescent rabbit anti-rat 
Ig reagent.  Tissues were fixed for 1 h  at  22°C in  70% ethanol, glacial acetic acid, and 40% 
formaldehyde solution in a volumetric ratio of 20:1 : 1, embedded in paraffin wax, and sectioned 
at 5-7 #m. 
Recirculating T lymphocytes were prepared by injecting 109 TDL, lymph node cells (LNC), 
or spleen cells intravenously into irradiated  (900 rads) syngeneic rats bearing a thoracic duct 
cannula. The cells which emerged from the cannula within 24 h of injection were >95% T cells 
as judged by absence of surface Ig, the presence of Pta  antigen,  and  positive staining with 
specificity W3/13. 
Mitotic Inhibition.  Vinblastine  (VBL)  was given by intravenous injection at  a  dose of 0.3 
mg/rat daily for two doses. Hydroxyurea (HU) was given twice daily in doses of 250 mg/kg for 
4 days. 
Cytotoxic alloantibodies were titrated with a modification of the Eosin exclusion method of 
Howard and Scott (17). 
Results 
First Set Graft Rejection in Normal Recipients and the Effect of Irradiation.  Rats of all the 
strains tested rejected hearts which differed at the major histocompatability complex 
in 6-8 days. Irradiation of recipients ablated the capacity to reject H-1 incompatible 
grafts.  Irradiated  PVG recipients did not reject  H-1  incompatible  heart  grafts for at 
least  40  days.  Although  there  was  an  inevitable  mortality  of about  15%  in  grafted 
recipients,  no insurmountable  surgical problems were encountered in grafting irradi- 
ated rats. Irradiated PVG rats grafted with hearts from DA donors were used to assay 
the capacity of cellular inocula prepared from PVG donors to restore graft rejection. 
Restoration of Graft Rejection with  Lymphoid  Cells.  The  ability  of cellular  inocula, 
prepared  from  various  lymphoid  organs,  to  restore  graft  rejection  was  assayed. 
Initially, varying numbers of LNC were injected  intravenously into irradiated  PVG 
recipients grafted with DA hearts.  It was found that the dose of lymphocytes used to 
restore  irradiated  recipients  correlated  with  the  duration  of graft survival.  5  X  l0  s 
LNC restored graft rejection to a tempo approximating that in intact rats. Fewer cells 
took longer to restore graft rejection. Increasing the dose beyond 5  X  10  s cells did not 
accelerate  rejection  beyond 8-10 days which therefore represents  a  maximum resto- 
rative effect (Table I). This suggests that with 5  X  10  s cells the assay rat is saturated 
with effector cell  precursors and at  this  dose and above the time taken  to reject  the 
graft reflects the duration of the physiological and immunological reactions required 
before tissue destruction is completed in irradiated  recipients.  This time is invariably 
1-2 days longer than  first-set rejection in normal animals. This probably reflects the 
time  required  for  adoptively  transferred  cells  to  regain  their  normal  physiological 
relationship  with  the host lymphoid tissue.  The demonstrable  quantitative  relation- 
ship between the number of cells given and the duration of graft survival meant that 
the adoptive transfer system could be used to measure the relative number of effector 
cell precursors in different  restorative inocula.  Therefore using cell doses of 5  X  108 
and less the restorative potency of cells from various tissues was titrated  (Table I). 
LNC  and  TDL  are  both  potent  in  restoring  rejection.  Thymocytes  and  bone 
marrow  are  not.  Unexpectedly  the  spleen  was  also  deficient  in  cells  competent  to B. M.  HALL, SUSAN DORSCH, AND BRUCE ROSER  881 
TABLE I 
Heart Graft Rejection in Irradiated PVG Rats* Restored with CeUs  from Various Lymphoid Tissues 
Source 
Restorative inoculum 
l0  s  5  X  10  s  2  X  l0  s  5  X  107  2  X  107 
LNC  9.6  ±  0.7  (5):[:  9.6 ±  0.8 (6)  14.3  ±  0.6 (6)  20.5  :t:  1 (6)  31.4  ±  1.6 (5) 
TDL  ND  8.4  :lz  0.2  (5)  11  -4-  2.3 (5)  ND  21.6:1:3.3  (5) 
Spleen  ND  21  +  1.1  (4)  28  ±  0.8 (7)  ND  36.2  ±  1.5  (5) 
Thymus  45  +  3.2  (5)  ND  54  +  2.6 (4)  ND  ND 
Bone marrow  ND  ND  69.6  :t:  2.5 (4)  ND  ND 
:1: Graft survival is expressed as the mean survival time (MST) of the group  ±  SEM (number in group). 
* MST of grafts in irradiated  PVG recipients not reconstituted with cells was 59  ±  5.3  (15). 
mediate graft rejection. To achieve equivalent rejection tempo required 10 times more 
spleen cells than LNC. TDL appeared slightly more potent than LNC. As evidence 
presented later in  this  paper  indicates that  the spleen,  like the thymus, and bone 
marrow contains relatively few recirculating lymphocytes, the distribution of cells 
able to cause graft rejection indicated by these assays is compatible with the thesis 
that effector cell precursors belong to the recirculating pool. It gives no information 
as to which of the subpopulations within this pool they represent. 
Roles of T and B Cells in Graft Rejection.  Using the in vitro techniques described in 
Materials  and  Methods  inocula of purified  Ig-  lymphocytes were prepared  from 
TDL and LNC populations and assayed for their ability to restore graft rejection. 
The effective absence of B cells in the purified inocula was confirmed by measuring 
the titer of specific alloantibody synthesis restored to adoptive recipients. Ig- cells, 
given  in  doses equivalent  to  the T-cell content of unfractionated cell  populations 
restored graft rejection with the same tempo as the unfractionated inocula. 2  ×  107 
unfractionated LNC caused rejection in 25.3  +  1.9 days. The Ig- cell equivalent (on 
the basis that 65% of LNC are Ig-) caused rejection in 27.8  +-_  1.2 days (0.4 >  P > 
0.3). While no antibody was detected in the recipients of purified Ig- cells, recipients 
of unfractionated cellular inocula showed titers of alloantibody only 4-8-fold lower 
than those of normal PVG rats grafted with DA skin (Fig. 1). The presence or absence 
of antibody in the serum did not affect graft rejection. Histological sections of rejected 
heart  grafts  from normal  animals or  those given Ig-  cells were scanned  and  the 
number  of plasma  cells/section  counted.  The  former  showed  a  profuse  cellular 
infiltrate containing 50-200 plasma cells per cross-section of myocardium at the mid- 
point of the long axis of the ventricles. The virtual absence of plasma cells in similar 
sections  of rejected  tissue  from  Ig-  cell  reconstituted  rats,  made  it  unlikely that 
antibody produced locally was effecting rejection in these recipients. 
The ability of purified Ig- cells to secure graft rejection and the high concentration 
of effector cell precursors in tissues rich in recirculating lymphocytes suggested that a 
recirculating T  cell might be the essential mediator of first-set graft rejection. 
Role  of Redrculating  Cells in  Graft Rejection.  Rapidly  recirculating  T  cells  were 
separated from normal populations of LNC, spleen cells, and TDL and their potency 
in graft rejection examined as follows:  109 cells from each population was injected 
into heavily irradiated syngeneic recipients bearing a thoracic duet fistula and timed 
collections of the cells emerging from the fistula were begun. B-cell stains were done 
on samples from each 90 rain collection and the rate of emergence of T  and B cells 
calculated (Fig. 2). Spleen cell suspensions yielded significantly fewer recirculating T 882  RECIRCULATING T  CELLS REJECT CARDIAC ALLOGRAFTS 
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cells than LNC or TDL. The peak output of cells from the thoracic duct of animals 
injected with spleen cells was 2.3  ×  106/h and the total T-cell output per recipient 
over the 48-h of collection 7.9  ×  107. This is in contrast to a peak output of 1.71  × 
107 and a  total recovery of 2.87  ×  10  a T  cells from animals injected with LNC and 
a peak output of 1.33  ×  107/h and total recovery of 3.23  ×  108 T  cells from animals 
injected  with  TDL  (Fig.  2).  The rapidly  recirculating  cells  from each  source were 
positively identified with T-cell-specific stains (Table II). In all three groups >95% of 
cells collected in the first 22 h  drainage were T  cells. Both unfractionated TDL and 
the rapidly recirculating fraction of cells showed uniform staining of the T  cells with 
anti-Pta and specificity W3/13 as expected. On unfractionated TDL the second-stage 
reagent (fluorescent rabbit anti-rat Ig) also stained B cells resulting in staining of all 
cells in  the preparation.  With  the anti-Thy-l.1  reagent  a  subpopulation  which  did 
not bear Thy-1.1 was highly enriched in the rapidly recirculating T-cell pool (85%) 
but comprised only a  minority of the cells in TDL (14%).  Because the second stage 
reagent (fluorescent sheep anti-rabbit Ig) did not cross-react with surface Ig on rat B 
cells it was possible to establish that a  proportion of B cells in TDL must also bear 
Thy- 1.1. 
When the restorative capacity of the three populations of recirculating T  cells was 
compared they were  found  to be equipotent.  107  recirculating  T  cells  from spleen 
caused  heart  graft rejection  with  the same tempo as  107  recirculating T  cells from 
TDL  or  LNC.  This  is  in  contrast  to  the  relative  potency  of the  unseparated  cell 
population  from  each  of  these  sources  (Table  III).  The  first  22  h  collection  of 
recirculating cells from the intermediate hosts injected with LNC contained  1.56  × 
108 ceils which was about seven times greater than the number in recirculating cells 
obtained  from spleen  (2.3  ×  107). The restorative potency of unfractionated  LNC B. M. HALL, SUSAN DORSCH, AND BRUCE ROSER  883 
was about 10 times the potency of unfractionated spleen cells. This is sufficiently good 
agreement to ascribe rejection to the recirculating T-cell content of these inocula. 
It was  concluded that:  (a)  spleen cell suspensions contain  a  significantly smaller 
proportion of recirculating cells than either TDL or LNC and  the poor restorative 
capacity of spleen cell populations is a reflection of this. (b) The recirculating T  cells 
obtained from spleen LNC and TDL are equipotent in graft rejection. (c) The cells in 
spleen, lymph nodes, and thoracic duct lymph which cause heart graft rejection are 
recirculating T  cells. 
Smears of the rapidly recirculating cells showed that more than 99% of them were 
typical small lymphocytes. Although these are known to be predominantly long-lived, 
experiments were done to determine whether the effector cell precursors were derived 
from this predominant pool or from a minority pool of short-lived cells. 
Life Span of Effector Cell Precursors 
ROLE OF Xn~ THYMUS.  The failure of neonatally thymectomized or congenitally 
athymic  mice  to  reject  grafts  indicates  that  the  precursor  cell,  like  all  T  cells,  is 
ultimately dependent on the thymus for its production. That adult thymectomy has 
little effect on the capacity of intact animals to reject allografts does not necessarily 
mean that the adult thymus does not play a role in maintaining the size of the pool 
of effector cell precursors throughout life. Loss of a continuing small output of long- 
lived cells from the thymus after adult thymectomy would not be evident for many 
months because of the redundancy of effector cell precursors in normal animals (Table 
I). 
The potency of inocula of cells prepared from the lymph nodes and thoracic duct 
lymph of donors thymectomized 3 mo previously was examined. These cells were, if 
anything, more potent in graft rejection than ceils from normal donors (Table IV). It 
is apparent that  the effector cell precursor is independent of thymic influence after 
the neonatal period and that cells recently derived from the thymus and seeded into 
the  recirculating pool are  inactive in  graft rejection and  in  fact dilute the pool of 
effector cell precursors.  This result gives no information as to whether effector cell 
precursors are individually long-lived cells or are derived from dividing T  cells in the 
periphery which are independent of thymic influence. 
Longevity of Effector Cell Precursors.  When given according to the regime outlined in 
Materials and Methods, VBL has been shown to ablate immune responses mediated 
by short-lived  lymphocytes, while  leaving unaffected those responses  mediated  by 
long lived cells (21). The dose of HU required to abolish DNA synthesis in the donors 
was established by titrating the degree of depression of tritiated thymidine uptake of 
bone marrow cells against increasing drug dosage. The regime finally adopted resulted 
in  >95%  depression of thymidine uptake and  a  reduction of 90% in the nucleated 
cells present in the marrow. 
LNC from treated animals showed no loss of GVH activity when compared with 
LNC of normal rats in the popliteal lymph node weight assay of Ford et al. (22). The 
effect of these inhibitors and the capacity of lymphocytes from naive donors to restore 
heart graft rejection is seen in Table IV. Restorative inocula prepared from animals 
treated with either agent showed no decrease in their potency to restore heart graft 
rejection  indicating  that  effector cell  precursors  were  not  recently  derived  from 
mitotically active progenitor cells. Taken with the ineffectiveness of adult thymectomy 16 
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TABLE  II 
T-Cell Markers on TDL and on Recirculating T Cells* 
885 
Membrane antigen  First stage reagent 
Second stage:]: re- 
agent (fluorescent) 
Fluorescent cells 
Recirculat- 
TDL 
ing T  cells 
(~ 
Ig  --  Rab a-rat Ig  46  1.5 
W3/13 epitope  Specificity W3/13§  "  98  99 
Pta A2 B  (not  1)  AUG a-HO serum [[  "  100  100 
Control  --  Sh a-Rab Ig  1  0 
Thy- 1.1  Rab a-Thy, 1.1¶  "  86  15 
* Recirculating  cells  recovered  from  the  lymph  within  24  h  of intravenous  injection  into  irradiated 
cannulated hosts. 
:t: Concentration, 0.3 g/liter. 
§  1.0 g/liter. 
II 1:4. 
¶ Undiluted. 
TAI~LE  III 
Comparison of the Potency of Recirculating T Cells  from  Various Lymphoid Tissues 
Unfractionated  Recirculating T  cells 
Source  Inoculum  Rejection time  Source  Inoculum  Rejection time 
TDL  1.5  X  10  s  11  2:0.3 (5)  TDL  7.5  x  107  10.9  2:0.4 (9) 
"  2  X  107  2t.6  2:3.3 (5)  "  107  26.4  ±  2.5 (5)* 
LNC  2  ×  107  31.4 2:1.6  LNC  107  25.5  2:2.3 (5):~ 
Spleen  2  ×  107  36.2 2:1.5  Spleen  107  24.8  2:2.1  (5)§ 
*':~'§ These groups are not significantly different (1,2  =  *, ~; 0.4 >  P >  0.3), (2,3  =  :~, §; 0.4 >  P >  0.3), 
(1,3  =  *, §; 0.4 >  P  >  0.3). 
TABLE  [V 
Effect of Thymectomy or Anti-Mitotic Agents on Potency of Restorative Inocula 
of LNC 
Restorative inoculum  Treatment  Rejection time 
1.5  ×  10  a  --  14.3  2:0.6 (6) 
1.5  ×  10  a  ATX*  10  zt: 0.4 (4) 
2  ×  107  --  24.5  2:3.3 (4) 
2  X  107  ATX*  20 +  0.7 (5) 
2  X  107  VBL  18  2:1.1  (4) 
2  X  107  HU  18.3  +  1.5 (4) 
* Donors were thymectomized at  12 wk of age 3 mo before donation of cells. 
Fro.  2.  The in vivo separation of recirculating T  cells from (a) TDL (b) LNC (c) spleen cells. 10  s 
cells from the population  to be separated were  injected  intravenously into  irradiated  (900  rads) 
syngeneic intermediate hosts bearing a  thoracic duet fistula and timed collections of lymph were 
begun. Samples from each  1.5 h  collection were stained for the presence of Ig+  cells. Each graph 
plots  the  mean  output  per  h  of recirculating  T  cells  (O)  and  B  cells  (O)  from  at  least  four 
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in reducing the proportion of precursor cells in the periphery, these results confirm 
that the precursor cells responsible for allograft rejection are neither recently formed 
nor short-lived. 
Discussion 
The mechanism whereby allogeneic tissue is actually destroyed in vivo is unknown. 
Although a  large body of in vitro work strongly implicates a cytotoxic T  cell as the 
most  likely effector mechanism  in  graft  rejection this  has  not  been  unequivocally 
shown to operate in the intact animal (23-25). The adoptive transfer assay described 
here makes it possible to examine the relevance of various cell populations, singly or 
in combination, to the process of graft rejection. The irradiated heart-grafted assay 
animal  is  >99.9%  depleted  of lymphocytes  but  contains  the  somatic  structures 
necessary for the physiological function of the immune system in vivo (7, 8).  Such 
animals  support  lymphocyte recirculation  through  normal  traffic  areas  (26),  and 
permit the normal differentiation of precursor cells into both T  effector and plasma 
cells and the synthesis of normal titers of antibody (including alloantibody). It has 
been  firmly  established  that  the  immune  responses  restored  to  such  animals  are 
mediated by the cells adoptively transferred to them (7, 8, 26) and not by a nonspecific 
stimulator,/effect on the animals own immune system. 
The results of adoptive restoration of heart graft rejection reported here establish a 
central  role  for  the  long-lived  recirculating  T  lymphocytes  in  first-set  allograft 
rejection. Not only were grafts rejected with normal tempo in rats restored with highly 
purified inocula of these cells,  but  the  concomitant  production of alloantibody in 
animals given B cells in addition had no effect on the tempo of rejection. A role for 
alloantibody has been demonstrated in hyperacute rejection in some species (27-29) 
and  its relevance to normal  first-set rejection deduced by inference (6).  It has also 
been suggested that small amounts of locally produced antibody may play a part in 
graft rejection (30).  Our observations indicate that first set rejection can be achieved 
in the absence of B cells, alloantibodies in detectable titer, or significant plasma cell 
infiltrate, and strongly suggest that B-cell-mediated responses are ancillary phenom- 
ena in the primary rejection of grafts expressing major alloantigens. 
The conclusion that the T  cells capable of causing rejection are in the recirculating 
pool  rests  upon  their  presence  in  large  numbers  in  tissues  known  to  be  rich  in 
recirculating lymphocytes and the direct demonstration that those cells in these tissues 
which  are responsible for first-set rejection do indeed recirculate rapidly. That the 
spleen  is  a  poor source of these cells was  unexpected in  view of previous evidence 
suggesting that the spleen contains large numbers of recirculating lymphocytes (31, 
32). This evidence is however essentially indirect. The finding that large numbers of 
injected  TDL  home  to  the  spleen  (33)  has  led  to  the  conclusion that  this  organ 
contains large numbers of recirculating lymphocytes (34).  When  this question was 
examined directly by testing the ability of spleen cells to recirculate from blood to 
lymph  it  was  obvious  that,  though  recirculating  cells  are  present  in  spleen  cell 
populations, they are poorly represented here in comparison with their proportions in 
lymph  nodes and  thoracic duct  lymph.  This can  be explained by the  much more 
rapid transit of recirculating cells through the spleen than the lymph nodes (31, 35) 
resulting in a low instantaneous content of recirculating cells in the former. 
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which deplete the recirculating pool (36, 37) might suggest that the precursors of cells 
which  mediate this response cannot be completely restricted to this pool.  However, 
first-set skin allograft rejection is routinely achieved by adoptive transfer of as few as 
3  ×  107  lymphocytes  (8)  which  is  about  2%  of the  recirculating  pool.  Depletion 
experiments would therefore not be expected to affect skin graft survival unless they 
were >98% effective, a level which cannot be practically achieved in vivo. In favor of 
restriction  of effector cell  precursors  to  the  recirculating  pool  are the  observations 
recorded in this paper that the small number of rapidly recirculating T  cells which 
can be isolated from spleen cell inocula are equipotent with recirculating cells derived 
from other  sources  and  that  the  distribution  of effector cell  precursors  within  the 
lymphoid  system  parallels  the  concentration  of recirculating  lymphocytes  in  the 
system. We would therefore conclude that both the necessary and sufficient mediator 
of first-set allograft rejection is a long-lived, recirculating T  cell. 
Summary 
The nature of the cells required for first-set graft rejection in vivo was examined by 
using an adoptive transfer system to restore heart-graft rejection  in  irradiated  rats. 
Highly purified inocula of peripheral T  lymphocytes were shown to quantitatively 
account for the restorative ability of adoptively transferred cells. These T  cells were 
shown to be long-lived small lymphocytes which  are not recently derived from the 
thymus  during  adult  life.  They  belong  to  the  pool  of T  ceils  which  constantly 
recirculate from blood to lymph as shown by their rapid appearance in the lymph of 
irradiated  syngeneic  rats  after  intravenous  injection.  Neither  B  lymphocytes  nor 
antibodies  in  the  circulation  or  in  the  graft  itself are  required  for  first-set  graft 
rejection. 
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